Scientists find out why tumor cells survive chemotherapy
Staff of the TSU Laboratory of Translational Molecular and Cellular Biomedicine are studying the role of innate immunity in the formation of tumor resistance to chemotherapy. The subject of the study is colorectal cancer, which is difficult to treat and is among the three most common cancers worldwide. The data obtained will help to determine the risk of developing resistance to chemotherapy drugs earlier and to choose the optimal treatment strategy.
According to the World Health Organization, colorectal cancer ranks third in malignant neoplasms in men and second in women. Over 10 years (2005–2015), the number of patients increased by 27.9 percent. In 2015, deaths from colon and rectal cancer reached 774,000 worldwide.
Read more: http://en.tsu.ru/news/scientists-find-out-why-tumor-cells-survive-chemotherapy/
